This Slide: #24 of 100 |
Slide #24. BioTelemetry, Inc. — Mednet Healthcare Technologies, Inc.
Acquirer:
BioTelemetry, Inc. (NASDAQ:BEAT)
Acquiree:
Mednet Healthcare Technologies, Inc.
Details:
BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a significant victory in the patent infringement case against Mednet Healthcare Technologies, Inc. and its subsidiaries, Heart-Care Corporation of America, Universal Medical Inc., and Universal Medical Laboratory, Inc. ("Mednet"), as well as other named defendants. Mednet entered into a consent judgment, declaring that the Mednet entities infringed on five patents owned by BioTelemetry and its subsidiary, Braemar Manufacturing, and that all five patents are valid.
HeartBeam is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Co.'s initial focus is providing diagnostic data to help physicians with care management of patients with cardiovascular disease. Co. is developing its telehealth Product to address the field of remote patient monitoring. Co.'s telehealth Product is comprised of a credit card sized ECG machine and a cloud-based diagnostic software exert system. Co. is applying its platform technology to create a software tool for detecting heart attacks in the Emergency Room environment.
Open the BEAT Page at The Online Investor »
|
Open the BEAT Page at The Online Investor (in a new window) »
Free BEAT Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: BEAT Stock Forecast Based on Zacks ABR data; powered by Xignite |